Considerations for Establishing Q1/Q2 Sameness of Complex Formulations (10of39) Complex Generics '18 скачать в хорошем качестве

Considerations for Establishing Q1/Q2 Sameness of Complex Formulations (10of39) Complex Generics '18

Bin Qin from CDER’s Office of Generic Drugs covers considerations for establishing Q1/Q2 sameness of complex formulations. ----------------------------- FDA CDER’s Small Business and Industry Assistance (SBIA) educates and provides assistance in understanding the regulatory aspects of human drug products & clinical research. Upcoming training and free continuing education credits: https://www.fda.gov/cdersbia CDER SBIA 2018 Playlist:    • 2018 CDER Small Business and Industry Assi...   LinkedIn:   / cder-small-business-and-industry-assistance   Training resources: https://www.fda.gov/cderbsbialearn Twitter:   / fda_drug_info   CDER small business e-mail update subscription: https://updates.fda.gov/subscriptionm... Email: CDERSBIA@fda.hhs.gov Phone: (301) 796-6707 I (866) 405-5367